Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Terns Pharmaceuticals, Inc. - Common Stock (NQ:TERN)

46.27 -0.20 (-0.44%)

Streaming Delayed Price Updated: 2:45 PM EDT, Mar 18, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,734,944
Open	45.72
Bid (Size)	46.23 (100)
Ask (Size)	46.30 (400)
Prev. Close	46.47
Today's Range	45.05 - 46.61
52wk Range	1.865 - 48.26
Shares Outstanding	61,071,897
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

This New $7 Million Bet Targets a CNS Drug Maker With Phase 3 Trial Underway and 27% Stock Gain ↗

Today 11:57 EDT

Axsome Therapeutics develops therapies for central nervous system disorders, with a late-stage pipeline targeting major unmet medical needs.

Via The Motley Fool

Sionna Stock Is Up 144% This Past Year. Is the Biotech a Buy as One Fund Makes a $7 Million Bet? ↗

Today 11:49 EDT

This clinical-stage biotech develops therapies targeting the root cause of cystic fibrosis, with a pipeline focused on CFTR modulators.

Via The Motley Fool

Performance

YTD	+15.3%	+15.3%
1 Month	+16.9%	+16.9%
3 Month	+7.8%	+7.8%
6 Month	+533.8%	+533.8%
1 Year	+1323.5%	+1323.5%

More News

This $6 Million Bet Adds a Brain Health Biotech to Portfolio Dominated by Clinical Stage Names ↗

Today 11:34 EDT

Via The Motley Fool

VKTX, TERN, GPCR Shares Rally As Novo Nordisk Sounds Willingness Towards Portfolio-Expansion Deals ↗

January 14, 2026

Via Stocktwits

This Biotech Fund Sold $8 Million of Terns Stock Last Quarter, but Here's Why It Still Seems Very Bullish ↗

Today 11:04 EDT

Via The Motley Fool

This Investor Sold $104 Million of Nuvalent Stock Amid Cancer Drug Developer's Nearly 30% Rally ↗

March 16, 2026

Via The Motley Fool

This Biotech Attracted a $181 Million Investment During a Staggering 1,300% Stock Rally ↗

March 16, 2026

Via The Motley Fool

Investment Firm Builds Position in TERN Stock, According to Recent SEC Filing ↗

March 05, 2026

Via The Motley Fool

Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences

February 25, 2026

From Terns Pharmaceuticals, Inc.

Via GlobeNewswire

ORBIMED Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing ↗

February 20, 2026

Via The Motley Fool

Fund Discloses $35 Million Biotech Buy Amid Staggering 830% Terns Stock Surge ↗

February 17, 2026

Via The Motley Fool

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

February 02, 2026

From Terns Pharmaceuticals, Inc.

Via GlobeNewswire

Terns Pharmaceuticals to Highlight 2026 Priorities and Program Milestones at the 44th Annual J.P. Morgan Healthcare Conference

January 07, 2026

From Terns Pharmaceuticals, Inc.

Via GlobeNewswire

Stay updated with the stocks that are on the move in today's after-hours session. ↗

January 02, 2026

Via Chartmill

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

January 02, 2026

From Terns Pharmaceuticals, Inc.

Via GlobeNewswire

Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

December 11, 2025

From Terns Pharmaceuticals, Inc.

Via GlobeNewswire

Terns Announces Pricing of Upsized $650 Million Public Offering

December 09, 2025

From Terns Pharmaceuticals, Inc.

Via GlobeNewswire

Terns Announces Proposed Public Offering

December 09, 2025

From Terns Pharmaceuticals, Inc.

Via GlobeNewswire

Terns Stock Surges 300% in One Year — What a New $43 Million Position Signals for Investors ↗

December 03, 2025

Via The Motley Fool

Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday ↗

November 17, 2025

Via Benzinga

Terns Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London

November 14, 2025

From Terns Pharmaceuticals, Inc.

Via GlobeNewswire

Terns Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Updates

November 10, 2025

From Terns Pharmaceuticals, Inc.

Via GlobeNewswire

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

November 04, 2025

From Terns Pharmaceuticals, Inc.

Via GlobeNewswire

Henry Schein, Sanmina, Wingstop, Waters And Other Big Stocks Moving Higher On Tuesday ↗

November 04, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 04, 2025

Via Benzinga

Frequently Asked Questions

Is Terns Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, Terns Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does Terns Pharmaceuticals, Inc. - Common Stock trade on?

Terns Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Terns Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for Terns Pharmaceuticals, Inc. - Common Stock is TERN on the Nasdaq Stock Market

What is the current price of Terns Pharmaceuticals, Inc. - Common Stock?

The current price of Terns Pharmaceuticals, Inc. - Common Stock is 46.27

When was Terns Pharmaceuticals, Inc. - Common Stock last traded?

The last trade of Terns Pharmaceuticals, Inc. - Common Stock was at 03/18/26 02:45 PM ET

What is the market capitalization of Terns Pharmaceuticals, Inc. - Common Stock?

The market capitalization of Terns Pharmaceuticals, Inc. - Common Stock is 2.83B

How many shares of Terns Pharmaceuticals, Inc. - Common Stock are outstanding?

Terns Pharmaceuticals, Inc. - Common Stock has 3B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.